Diabetologists in India are up in arms following an unexpected decision by the government there to suspend sales of the diabetes drug pioglitazone (Medscape)
Diabetes News Service
Glycosmedia is also available as an App:
For iPhone and iPad | For Android devices
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
